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Abstract 
A 7-year old female neutered Jack Russell Terrier was presented to Langford Vets, 
University of Bristol with a chronic history of intermittent lethargy. Investigations and 
clinical course were compatible with hereditary hemolysis due to a red blood cell membrane 
defect. Proteomics was utilized to explore protein alterations in the presence of a 
hypothesized red blood cell membrane protein deficiency. The proteomic analysis revealed a 
down-regulation of the proteins band 3, alpha and beta adducin and alterations to the red 
blood cell proteome consistent with previous reports of changes accounted for by the 
presence of a reticulocytosis and ongoing hemolysis. The spectrum of protein alterations 
identified in the affected dog may be homologous to a band 3 protein deficiency secondary to 
hereditary spherocytosis as described in man. 
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Case presentation 
 
Hemolysis as a result of hereditary hemolytic anemia has been described in people and 
domestic animals including the dog and cat1-3. Etiologies of hereditary hemolytic anemia can 
be categorized as enzymopathies, hemoglobinopathies, or red blood cell (RBC) membrane 
defects2. Clinical signs in affected patients are variable; some phenotypes are typically fatal 
in early life whereas others are reported to be detected as an incidental finding3,4.  Despite a 
high index of suspicion, pinpointing the underlying defect can be challenging in human 
medicine5. In people diagnosed with hereditary spherocytosis where clinical features are 
more severe than the hypothesized phenotype, further investigations into the underlying 
etiology are recommended. Recent published guidelines recommend the use of SDS-PAGE 
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to explore alterations to the erythrocyte protein profiles, followed by sequence analysis of the 
membrane protein genes when the protein results do not explain the clinical outcome or mode 
of inheritance6. In tandem with these recommendations, high-throughput proteomic analysis 
has been applied to patients presenting with hereditary hemolysis and in some cases 
identified hypothesized protein deficiencies5,7. 
 
Red blood cells, aside from reticulocytes, are particularly attractive for proteomic analysis 
due to their lack of internal membrane bound organelles and nucleus, resulting in limited 
complexity. Proteomics has been applied to the study of RBCs since 2002 with particular 
emphasis on the assessment of protein defects in specific disease presentations, in changes to 
RBCs over time with storage, and in directing development of new drugs, for example anti-
malarial drug therapy8. 
 
The following report describes to the authors’ knowledge the first application of proteomics 
to further explore the cause and consequences of a presumed RBC membrane protein 
deficiency in a dog presenting with hereditary hemolysis. 
 
A 7-year old female neutered Jack Russell Terrier was presented with a history of chronic 
intermittent lethargy. CBC (EDTA blood, Abbot Cell-dyn 3700) and biochemistry (serum, 
Komelab Prime 60i) were performed. Hemolysis was suspected based upon a persistent 
reticulocytosis, occasional spherocytes, and an acute drop in hematocrit during a 24 hour 
hospitalization period associated with lethargy, hemoglobinuria and stable plasma proteins 
(Table 1, Day 30 to Day 31).  
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Investigations were directed at the potential causes of hemolysis, specifically immune-
mediated disorders, toxins, or infectious causes. Immune-mediated RBC destruction 
including immune-mediated hemolytic anemia and hemophagocytic syndrome were excluded 
based on history, clinical course and investigation findings including a negative direct 
antiglobulin test (rabbit anti-canine complement (C3b), IgG and IgM sera at 4 and 38°C, 
Langford Vets Diagnostic Laboratories, University of Bristol), and, thoracic and abdominal 
CT imaging, ultrasound guided hepatic and splenic fine-needle aspirates, and bone marrow 
aspirate cytology respectively. Findings revealed extramedullary hematopoiesis and 
hemosiderin within the liver and spleen and erythroid hyperplasia on bone marrow cytology, 
consistent with increased RBC turnover. Imaging did not reveal a metallic foreign body and 
evidence of ongoing compensated hemolysis had been documented over a two month period 
with no known exposure, therefore a toxin was considered unlikely. Infectious disease 
screening for Babesia spp., haemoplasma spp., Ehrlichia spp., Anaplasma spp., and 
Leptospira spp. was negative.  
 
Hemoglobin-oxygen dissociation and osmotic fragility testing were performed to assess for a 
hereditary RBC defect. Samples from the affected case and the healthy control dog were 
shipped on ice and processed simultaneously for osmotic fragility testing and hemoglobin-
oxygen dissociation curves at PennGenn (PennGenn Laboratories, University of 
Pennsylvania) as previously described.1,9 The hemoglobin-oxygen dissociation curve was 
found to be comparable to the control and within the reference range (see Figure 1).  
Hemoglobinopathies and RBC enzyme deficiencies including pyruvate kinase and 
phosphofructokinase deficiencies result in a shift in the oxygen-dissociation curve10-14, and 
thus were considered unlikely. In contrast, RBC membrane disorders are not anticipated to 
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result in a shift in the oxygen-dissociation curve and were therefore still considered a 
possibility in the affected case15. 
 
The patient had a markedly abnormal osmotic fragility (OF) test result (Figure 2, case 50% 
hemolysis at 67% saline dilution, control at 41% saline dilution), consistent with increased 
RBC fragility. The lysis curves for erythrocytes from the control and affected dog did not 
overlap, indicating the entire population of RBCs were more fragile1. The OF test evaluates 
the extent of hemolysis of RBCs at increasingly hypotonic solutions of saline. Hemolysis 
occurs due to a breakdown in osmotic regulation and loss of volume control, resulting in cell 
swelling and concomitant loss of surface until they reach a critical hemolytic volume after 
which lysis occurs16. RBCs can have an increased tendency to hemolyze during OF testing 
due to diminished active transport (e.g. pyruvate kinase deficiency), increased membrane 
permeability (e.g. spectrin deficiency)17 and/or reduced RBC surface area (e.g. 
spherocytes)16. The results of the hemoglobin-oxygen dissociation and osmotic fragility 
testing, in combination, were supportive of a RBC membrane defect in the affected dog18.  
 
Scanning electron microscopy was performed to further evaluate the RBC structure (Figure 
3) of the case and control dog. Blood samples for electron microscopic studies were 
anticoagulated with lithium-heparin and 80µl of this heparinized blood was mixed with 500µl 
of 2.5% glutaraldehyde (v/v) in 0.1M HEPES buffer at pH 6.8. Aliquots of samples were 
applied to glass slides and samples were dehydrated though a graded ethanol series before 
critical point drying. Samples were sputter-coated with 15 nm of silver and examined with a 
Jeol 6330 field emission scanning electron microscope. No obvious structural abnormalities 
were identified.  
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Based upon a strong suspicion of a hereditary RBC membrane protein deficiency, proteomic 
analysis of the RBC membrane proteins was performed using quantitative high-throughput 
mass spectrometry and the relative amounts of the proteins identified in the patient compared 
to those in a healthy age matched control dog determined. 
 
Proteomic analysis 
 
Red blood cell ghost preparation 
Four samples from the control and affected dog were treated individually, pooled and 
analyzed (i.e. four per animal). RBC membrane ghosts were prepared from EDTA 
anticoagulated blood by washing 2.5ml of sample six times in 25ml phosphate buffered 
saline at pH 7.4 with aspiration and removal of the supernatant and buffy coat after 
centrifugation on a density gradient (600 x g for 5 min, Histopaque 1077; Sigma-Aldrich). 
The RBCs were then lysed by adding 10 volumes of ice-cold lysis buffer (20mM Tris-HCl, 
pH 7.6) and pelleted by centrifugation at 40,000 g for 30 min at 4°C. The supernatant and 
opaque buttons of residual leukocytes were removed using a pipette, leaving the translucent 
RBC membranes. The membranes were washed a minimum of four times in ice-cold lysis 
buffer, until the supernatant was clear of hemoglobin and the RBC ghosts were obtained. 
After the final wash the supernatant was again discarded and 200µl of lysis buffer added. The 
concentration of proteins in each sample was measured against a standard curve using the 
Qubit® Protein Assay and the Qubit 2.0 Fluorimeter (Invitrogen Eugene, Oregon, USA, 
Turner Biosystems). The samples were then stored at -80°C prior to proteomic analysis. 
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Tandem Mass Tag (TMT) labelling and cation exchange chromatography 
 
Aliquots of 63µg of control (700µl) and case (300µl) protein extracts were digested with 
trypsin (2.5µg trypsin per 100µg protein; 37°C, overnight) and labelled with TMT 6plex 
reagents according to the manufacturer’s protocol (Thermo Fisher Scientific, Loughborough, 
LE11 5RG, UK).  After labelling, samples were combined and a 50µg aliquot of this pooled 
sample evaporated to dryness and resuspended in 50µl of Buffer A (10mM KH2PO4, 
25%MeCN pH 3) prior to fractionation by strong cation exchange using an Ettan LC system 
(GE Healthcare).  In brief, 48µl of sample was loaded onto a PolysulphoethylA column (100 
x 2.1mm, 5µm, 200A; PolyLC Inc.) in buffer A and peptides eluted with an increasing 
gradient of buffer B (10mM KH2PO4, 25%MeCN 1M KCl pH 3) from 0-100% over 30 
minutes.  The resulting 15 fractions were evaporated to dryness, resuspended in 5% formic 
acid and then desalted using SepPak cartridges according to the manufacturer’s instructions 
(Waters, Milford, Massachusetts, USA)).  Eluate from the SepPak cartridge was again 
evaporated to dryness and resuspended in 40µl of 1% formic acid prior to analysis by nano-
LC MSMS using an LTQ-Orbitrap Velos Mass Spectrometer with 15µl for each run.   
 
Nano-LC Mass Spectrometry 
Cation exchange fractions were further fractionated using an Ultimate 3000 nanoHPLC 
system in line with an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific).  In brief, 
peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18 nano-trap 
column (Thermo Scientific). After washing with 0.5% (vol/vol) acetonitrile 0.1% (vol/vol) 
formic acid, peptides were resolved on a 250 mm × 75 μm Acclaim PepMap C18 reverse 
phase analytical column (Thermo Scientific) over a 150 min organic gradient, using 7  
gradient segments (1-6% solvent B over 1min, 6-15% B over 58min, 15-32%B over 58min, 
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32-40%B over 5min, 40-90%B over 1min, held at 90%B for 6min and then reduced to 1%B 
over 1min.) with a flow rate of 300 nl min−1.  Solvent A was 0.1% formic acid and Solvent B 
was aqueous 80% acetonitrile in 0.1% formic acid.  Peptides were positively ionized by 
nano-electrospray ionization at 2.0kV using a stainless steel emitter with an internal diameter 
of 30 μm (Thermo Scientific) and a capillary temperature of 250°C. Tandem mass spectra 
were acquired using an LTQ-Orbitrap Velos mass spectrometer controlled by Xcalibur 2.0 
software (Thermo Scientific) and operated in data-dependent acquisition mode.  The Orbitrap 
was set to analyze the survey scans at 60,000 resolution (at m/z 400) in the mass range m/z 
300 to 1800 and the top ten multiply charged ions in each duty cycle selected for MS/MS 
fragmentation using higher-energy collisional dissociation (HCD) with normalized collision 
energy of 45%, activation time of 0.1 ms and at a resolution of 7500 within the Orbitrap.  
Charge state filtering, where unassigned precursor ions were not selected for fragmentation, 
and dynamic exclusion (repeat count, 1; repeat duration, 30s; exclusion list size, 500) were 
used.  
 
The raw data files were processed and quantified using Proteome Discoverer software v1.2 
(Thermo Scientific) and searched against the UniProt Canis familiaris database [9615] 
(database downloaded 31-12-2014; 28492 entries) using the SEQUEST algorithm.  Peptide 
precursor mass tolerance was set at 10ppm, and MS/MS tolerance was set at 20mmu.  Search 
criteria included oxidation of methionine (+15.9949) as a variable modification and 
carbamidomethylation of cysteine (+57.0214) and the addition of the TMT 6plex mass tag 
(+229.163) to peptide N-termini and lysine as fixed modifications. Searches were performed 
with full tryptic digestion and a maximum of 1 missed cleavage was allowed.  The reverse 
database search option was enabled and all peptide data was filtered to satisfy false discovery 
rate (FDR) of 1%.  Quantitation was done using a peak integration window tolerance of 
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0.0075Da with the integration method set as the most confident centroid.  The resultant data 
file was filtered to remove proteins identified by less than 2 peptides. For each protein, the 
relative amount in the case compared to the amount in the control was presented as a ratio. 
The ratios were normalized by adjusting the values relative to the median ratio value which 
was set at 1. A full list of the proteins and associated details is shown in Supplementary Table 
1. 
 
Bioinformatics 
Initially a bottom-up (shotgun) approach was used to interrogate the proteomics data, in 
particular candidate proteins whose deficiencies have previously been described to cause 
RBC membrane defects resulting in altered osmotic fragility associated with spherocytosis 
were interrogated19-21 (Table 2, results considered likely to be impactful in bold). Analysis 
revealed a greater than 2 fold decrease in the amounts of alpha and beta adducin in the case 
compared to the control and band 3 protein was found to decrease by 1.88 fold in the affected 
dog. Identifying multiple protein deficiencies is not uncommon in proteomic analysis of 
putative RBC membrane disorders and can often be explained by the presence of a molecular 
defect resulting in a primary deficiency with secondary deficiencies due to decreases in 
proteins with which the primary protein interacts. Studies have hypothesized that the type and 
amount of secondary protein deficiencies may be involved in the hematological and clinical 
outcome as a result of enhanced membrane destabilisation.20,22,23 A concomitant decrease in 
band 3, alpha and beta adducin with preserved gamma adducin is the characteristic 
combination of protein deficiencies seen with a primary band 3 protein deficiency, with 
evidence that the band 3-adducin bridge is crucial to membrane stability.24 Primary band 3 
deficiency also results in variable decreases in protein 4.2, which may also account for the 
identified decrease in this protein level.23 
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Proteins that were found to be increased or decreased by ≥ 2 fold in the RBC protein 
preparation from the affected case compared to the control dog were analyzed using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) v 6.725 and the 
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) 9.1 database26 to 
identify classes of proteins belonging to specific processes and pathways that were over-
represented. A total of 408 proteins were identified with high confidence (identified by at 
least 2 peptide matches), of which 252 proteins were found to be increased or decreased more 
than two fold in the patient compared to the control (Supplementary data – S1). In this study 
a two-fold change was taken as the cut-off value to identify proteins that were significantly 
altered in amount7. This approach allowed exploration of the protein differences identified in 
the presence of a reticulocytosis and hemolysis as previously described5,27-30. For proteins 
that increased in amount in the affected dog compared to the control, DAVID analysis 
revealed an enrichment of proteins associated with the functional annotation terms “citrate 
cycle (TCA cycle)”; and “oxidative phosphorylation” whilst proteins that decreased were 
associated with the functional annotation terms “proteasome”; “chaperonin-containing T-
complex” and “intermediate filament protein” (Table 3). These results were supported by 
STRING network analysis that revealed a significant enrichment of proteins that 
increased/decreased in amount in known interaction networks that were associated with the 
KEGG pathway terms “metabolic pathways” and “proteasome” respectively (Figures 4 and 
5). 
 
Analysis of proteins in specific functional annotation clusters revealed that proteins 
previously described as up or down regulated in the presence of a reticulocytosis were altered 
in the affected dog compared to the control (see Table 4) 27,28,30. Results were in agreement 
with previous studies and revealed the affected dog had decreased amounts of carbonic 
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anhydrase 1 and 2 and increases in proteins associated with organelles including calregulin, 
the 60-kDa heat shock protein, ATPase synthase subunit alpha and the 78-kDa glucose 
regulatory protein compared to the control dog. In addition, there were increased amounts of 
CD55 (decay accelerating factor), transferrin receptor, erythrocyte band 7 and prohibitin in 
the case compared to the control, these proteins are known to be unique to reticulocytes. 
Carbohydrate metabolism was also altered as previously described, including decreased 
malate dehydrogenase28. 
 
This study also uncovered protein alterations previously identified in studies of people with 
hereditary hemolytic anemia, hypothesized to be related to the presence of increased red 
blood cell turnover and increased oxidative injury (see Table 5) 5,29. In particular, the affected 
dog displayed alterations in proteins involved in the cytoskeleton (e.g. GTPases), oxidative 
stress and endogenous protein quality control pathways (e.g. those involved in the glutathione 
synthetic pathway, chaperones and heat shock proteins) and down-regulated proteins 
involved in the ubiquitin-proteasome system including T complex proteins and 26S 
proteasome subunits. 
 
The dog was managed with oral folate and is alive at 4 years following diagnosis. Follow-up 
hematologies have revealed stable results. The dog reportedly displays occasional reluctance 
to exercise, particularly the day after vigorous play, but is otherwise free of clinical signs. 
 
Discussion 
Proteomics was applied to further investigate presumed hereditary hemolytic anemia in a 
dog. The results suggested alterations in amounts of key membrane proteins in particular 
band 3 and alpha and beta adducin whilst other protein levels were comparable to the control 
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dog including alpha and beta spectrin and ankyrin. Interestingly, this same pattern of protein 
derangements has previously been reported in people with a diagnosis of a primary band 3 
deficiency29. The proteomic approach used here is recognized as a diagnostic approach when 
investigating hereditary spherocytosis in people5-7 however, to the authors’ knowledge this 
technique has not been previously applied to a dog. Proteomics also uncovered a difference in 
protein levels between the affected and control dog, highly consistent with previous 
descriptions accounted for by the presence of a reticulocytosis and ongoing haemolysis27,28,30. 
 
A primary band 3 protein deficiency is the most common membrane defect described in 
people with hereditary spherocytosis with South European ancestry, and is typically inherited 
in a dominant fashion, with de novo mutations that are described. The severity of clinical 
signs appear to be associated with the extent of the deficiency and individuals often present in 
adulthood.31 
 
Red blood cell membrane protein defects resulting in increased OF have been described 
previously in dogs. Spectrin deficiency was identified using a radioimmune assay (RIA) in a 
population of Dutch Golden Retrievers with persistent increased OF3. In addition, protein 
band 4.1 deficiency was identified in a dog with compensated hemolysis and persistent 
reticulocytosis using SDS-PAGE.32 In contrast, two recent studies in cats described a strong 
suspicion of a RBC membrane defect but were unable to elucidate the protein responsible1,33 
despite one study using SDS-PAGE. SDS-PAGE analysis of the RBC proteome was not 
performed for the affected dog and may have uncovered protein alterations without the 
requirement for mass spectrometry (either in conjunction with SDS-PAGE or as part of 
quantitative proteomics). Given the improved sensitivity of a quantitative bottom-up 
proteomic approach21 over SDS-PAGE (in the absence of concurrent mass spectrometry) 
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there may be a role for this as a tool to screen for candidate proteins in such cases with 
unexplained osmotic fragility in the future. Recently, next-generation sequencing has been 
used to identify genetic mutations that result in RBC membrane deficiencies 34. Next-
generation sequencing is complementary to the approach used in this investigation and its use 
in this investigation could have further supported the hypothesis regarding the affected case 
generated by proteomic analysis.34 
 
In people with hereditary spherocytosis consensus recommendations for treatment are 
described6. Splenectomy is advised for severely or moderately affected individuals as the 
spleen is thought to be a hostile environment for the fragile RBCs (due to its low pH and 
oxidative stress) and folate supplementation was previously implemented for all cases, 
although now recommendations reserve it for circumstances where a folate deficiency is 
possible (e.g. socioeconomic environment such as poverty) or in moderate and severe cases. 
The justification for supplementation in the affected dog was that despite normal serum folate 
levels, a predominantly fish-based diet meant it was considered at mild risk of low dietary 
intake. Approximately 15% of people are asymptomatic apart from during periods of 
erythroid stress such as viral illness or splenomegaly therefore urgent medical attention is 
advised in the event of any febrile illness and antimicrobial prophylaxis recommended if any 
surgery is performed given the risk of decompensation. 
 
Interestingly, many of the proteins up and down regulated in human patients with hemolytic 
anemia and reticulocytosis were also identified as differentially expressed in the affected dog 
compared to the control dog. Previous studies have described techniques to reduce 
reticulocyte numbers prior to analysis,35 whilst extensive RBC washing and elimination of 
the top layer of the RBC pellet after centrifugation was performed specific attempts to reduce 
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reticulocyte numbers were not performed in this study, although this is unlikely to have had a 
significant impact upon the analysis given the relatively small proportion of reticulocytes in 
the sample. 
 
A limitation of the study was the numbers of samples analyzed, in similar studies of human 
patients with hereditary spherocytosis small numbers of control subjects are also described 
with an emphasis on the quantitative alterations in proteins in these patients5,29. In spite of 
this limitation the comparable findings to studies exploring the RBC membrane proteome in 
human patients with hereditary spherocytosis imply relevant findings, although further 
studies into the canine RBC proteome would be valuable in supporting this result. 
 
In conclusion, high-throughput proteomic analysis enabled detailed exploration of the protein 
changes associated with non-immune mediated hemolytic anemia in a dog. Interestingly, 
identified protein alterations displayed strong similarities to those described in people 
investigated for hereditary spherocytosis using proteomics. 
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Table 1 - Serial hematology results 
Parameter Day 1 Day 7 Day 30 Day 31 Day 61 Day 
150 
Day 
420 
Day 
1095 
Reference 
range 
Hb (g/dl) 13.1 15.6 15.0 12.5 14.5 14.3 15.8 14.6 12.0-18.0 
HCT (L/L) 43.0 49.0 51.0 41.8 49.5 47.4 54.2 45.0 35.0-55.0 
RBC (x 109/l) 5.94 6.93 6.80 5.58 6.61 6.33 7.33 6.89 5.00-8.50 
MCV (fl) 72.4 70.7 75.0 74.8 74.9 74.9 73.9 65.3 65.0-75.0 
MCHC (g/dl) 30.5 31.8 29.4 29.8 29.3 30.1 29.1 32.4 34.0-37.0 
Reticulocytes (x 
1012/l) 
229.9 478 310 370 570 670 350 352 < 60 
Blood smear 
evaluation 
Sphero
cytes 
(1+) 
Sphero
cytes 
(1+) 
Anisoc
ytosis 
(1+) 
Sphero
cytes 
(1+) 
Anisocyt
osis (1+) 
Aniso
cytosis 
(1+) 
Aniso
cytosis 
(1+) 
Anisoc
ytosis 
(1+) 
- 
 
 
Table 2 – Proteomic results for candidate proteins 
Candidate protein Uniprot 
acc.no. 
MW 
(kDa) 
pI % Coverage Protein Ratio 
(case/control) 
Ankyrin-1 F1PRD8 203.8 6.19 25.96 0.732 
Spectrin alpha chain E2R1P6 118.0 4.89 30.23 0.834 
Spectrin beta chain F1Q253 268.0 5.31 28.80 0.828 
Protein 4.1 J9P7E1 93.2 5.64 28.40 0.880 
Protein 4.2 F1PD51 77.4 6.79 20.78 0.640 
Anion exchange 
protein 3 (Band 3) 
J9NWP9 95.1 6.57 17.02 0.543 
Alpha Adducin E2RJW7 81.1 5.76 20.49 0.475 
Beta Adducin F6XYK7 79.6 5.92 29.36 0.359 
Gamma Adducin E2QZE7 79.0 6.18 3.82 1.255 
 
Table 3. DAVID analysis of proteins significantly altered in amount in RBC membranes 
isolated from case compared to the control dog.  
 Functional annotation terma 
>2 fold increase Citrate cycle (TCA cycle) (10.37) 
 Fatty acid beta-oxidation (8.12) 
 Protein folding/cell redox homeostasis/oxidoreductase 
(5.18) 
 Oxidative phosphorylation (5.1) 
>2 fold decrease Proteasome (7.84) 
 Chaperonin-containing T-complex (6.18) 
 Intermediate filament (5) 
 Proteasome regulatory particle, base subcomplex (3.93) 
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aThe total list of proteins that showed a >2 fold change in abundance in RBC membranes from the case compared to the 
control dog were analyzed for the presence of enriched groups of proteins and proteins involved in specific host pathways 
using DAVID. The functional descriptors for the 4 clusters of proteins that were most enriched for each category (with an 
EASE score greater than 1.3 (corresponding to a p value < 0.05)) are shown with the corresponding EASE score.  
Table 4 – Protein changes previously accounted for by presence of reticulocytosis 
Protein Uniprot 
acc.no. 
MW 
(kDa) 
pI % Coverage Protein Ratio 
(case/control) 
Carbonic anhydrase 1 F1PBK6 29.0 7.12 11.49 0.323 
Carbonic anhydrase 2 F1PDY8 29.2 7.18 26.92 0.264 
Calregulin F6UYJ9 47.1 4.55 4.19 2.677 
60 kDa Heat Shock 
Protein 
E2QUU5 61.0 6.00 19.72 7.916 
ATP synthase subunit 
alpha 
E2RNG2 59.6 9.04 26.58 5.904 
78kDa glucose 
regulatory protein 
F1PIC7 72.2 5.16 21.71 2.404 
C55 (decay 
accelerating factor) 
F1PCI2 37.1 7.78 13.06 2.530 
Transferrin receptor F1PEN6 86.5 6.30 7.66 3.732 
Erythrocyte band 7 F1PFS1 25.6 7.11 24.46 2.632 
Prohibitin A8W340 29.8 5.76 28.68 6.286 
Malate dehydrogenase Q0QF34 31.1 7.64 20.54 4.443 
 
 
Table 5 – Protein changes previously accounted for by hemolysis 
Protein Uniprot 
acc.no. 
MW 
(kDa) 
pI % Coverage Protein Ratio 
(case/control) 
CDC42 (GTPase) P60952 21.2 6.55 16.75 0.348 
Glutathione peroxidase F6XH46 17.3 5.57 25.32 0.434 
14-3-3 protein epsilon 
(Chaperone) 
J9P9V0 14.4 5.12 12.9 0.113 
Heat shock 70kDa 
protein 
E2RT63 94.3 5.16 13.93 0.193 
CCT8 (T complex 
protein) 
E2RQ81 59.7 5.68 10.04 0.327 
PSMC2 (26S proteasome 
subunit) 
F1PPH7 48.6 5.95 19.63 0.269 
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Figure 1 – Hemoglobin-oxygen dissociation curve 
 
A graph depicting haemoglobin-oxygen dissociation curve from the case and a healthy age-matched control 
dog. The percentage saturation is shown on the vertical axis and the increments of partial pressure oxygen on 
the horizontal axis. The one-half saturation point (p50) is found to be comparable between the case and control 
dog (case p50 28.3mmHg, reference range 26-30mmHg, control 29.1mmHg). 
 
 
Figure 2 – Osmotic fragility test 
 
Osmotic fragility (OF) test results from the case and healthy age-match control dog. The curve for the affected 
case is right-shifted consistent with increased OF and hemolysis occurring at higher concentrations of sodium 
chloride. 
 
Figure 3 - Electron microscopy of case RBCs 
Scanning electron microscopic pictures of red blood cells (RBCs) from the affected dog, no obvious 
abnormalities were identified. 
 
Figure 4 and 5. Protein association networks detected using the STRING database.  
 
Proteins that were altered in abundance either figure 4) > 2 or figure 5) < 2 fold respectively in the RBC membranes from 
the affected dog compared to the control dog were analyzed using STRING. The nodes shaded in red indicate proteins that 
were most significantly enriched for a specific GO Biological Process/KEGG pathway term in each STRING network 
displayed. For the proteins that increased >2 fold the KEGG pathway term “Metabolic pathways” (P = 3.72 x 10-25, gene set 
= 49)” was identified, whilst for proteins that decreased >2 fold, the GO/KEGG pathway term “Proteasome” (P = 1.06 x 10-
32, gene set = 20) was identified. 
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